The UK Centre for Health Solutions launched its report The challenge of compliance in life sciences: moving from cost to value at the Financial Times Global Pharmaceutical and Biotechnology Conference in association with Deloitte. The report, which is based on interviews conducted with senior compliance leaders in 11 major life sciences companies and Deloitte’s experience working with the industry,Read more
A view from the Center
for Health Solutions
Filter by category or month:
Health care is the largest industry in our economy. It consumes 17.4 percent of the US gross domestic product (GDP) and is projected to increase to 18.5 percent in the next five years. We need to innovate to break that trend. And, the optimist in me believes that five years is just enough time to create the innovations we need in health care—not only to lower the trend,Read more
If it isn’t broken, don’t fix it. Or so the old saying goes.
In the break-neck world of mergers, acquisitions, and consolidations in life sciences and health care, businesses are often bought or absorbed not because they are broken but because they are thriving and leaving their mark in a key targeted segment of the marketplace.Read more
My mother-in-law is awesome (I’ve had a few, so I feel qualified to judge). One of the things we share is a love of cooking. Sandy makes incredible, elaborate meals that delight our entire extended family, from babies to seniors.
My approach, by contrast, is a bit different. I have enjoyed cooking all my life,Read more
Disruption is inevitable. Nearly 100 years ago, the average rate of survival of companies in the S&P 500 was 67 years. Today, it’s 15. And Yale researchers estimate that 75 percent of those firms will be replaced with new ones by 2027.
Just as Uber transformed the taxi industry and Airbnb is able to rent millions of rooms without owning a single hotel,Read more
While the infectious disease burden is still a pressing issue around the world, many regions are also facing an explosion of the same chronic and lifestyle diseases that are impacting the developed world. Programs like the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) have enabled great strides against diseases like HIV/AIDS, for example. But sadly,Read more